NeoGenomics(NEO) - 2021 Q4 - Annual Report

Washington, DC 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION NEOGENOMICS, INC. (Exact name of registrant as specified in its charter) FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-35756 For the transition period from _________ to __________ 9490 NeoGenomics Way, Fort Myers, FL 33912 (A ...